Abstract
Little is known about the cytokeratin (CK) expressions in glioblastoma multiforme (GBM). The aim is to explore the CK expression in GM using immunohistochemistry (IHC). IHC study in 30 cases (median = 68 years, SE = 12.6) of GBM in brain. CK expression using AE1/3 antidody was seen in 29/30 (97 %) cases. There were no expressions of CK34BE12, CK5, CK6, CK7, CK8, CK14, CK 18, CK19, and CK20. Expression of p53 and glial fibrillary acidic protein (GFAP) were recognized in all 30 cases (100 %). All cases showed Ki-67 antigen labeling, index of which ranged from 6 to 43 % (m ± SD = 24 + 16). The IHC using CKAE1/3 in GBM very frequently shows positive reaction. The expression may cause difficulty in pathologic diagnosis in GBM, particularly in discrimination between GBM and metastatic carcinoma. The CK positivity in GM may be due to CK molecules other than CK34BE12, CK5, CK6, CK7, CK8, CK14, CK18, CK19 and CK20. GBM frequently expression p53 and high Ki-67 labeling.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cosgrove M, Fitzgibbons PL, Sherrod A, Chandrasoma PT, Martin SE (1989) Intermediate filament expression in astrocytic neoplasms. Am J Surg Pathol 13:141–145
Ng HK, Lo ST (1989) Cytokeratin immunoreactivity in gliomas. Histopathology 14:359–368
Cosgrove MM, Rich KA, Kunin SA, Sherrod AE, Martin SE (1993) Keratin intermediate filament expression in astrocytic neoplasms: analysis by immunocytochemistry, western blot, and northern hybridization. Mod Pathol 6:342–347
Hirato J, Nakazato Y, Ogawa A (1994) Expression of non-glial intermediate filament proteins in gliomas. Clin Neuropathol 13:1–11
Oh D, Prayson RA (1999) Evaluation of epithelial and keratin markers in glioblastoma multiforme: an immunohistochemical study. Arch Pathol Lab Med 123:917–920
Goswami C, Chatterjee U, Sen S, Chatterjee S, Sarkar S (2007) Expression of cytokeratins in gliomas. Indian J Pathol Microbiol 50:478–481
Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y (2002) Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int 52:740–746
Masica DL, Karchin R (2011) Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival. Cancer Res 71:4550–4561
Jung TY, Jung S, Kim IY, Moon KS, Jang WY, Park SJ, Kim YH, Kim HS, Min JJ, Kim J (2012) Pathologic analysis of glioblastoma via multiple stereotactic biopsies of active tumor and necrosis. Oncol Rep 27:707–713
Conflict of Interest
The author has no conflict of interest
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Terada, T. Expression of Cytokeratins in Glioblastoma Multiforme. Pathol. Oncol. Res. 21, 817–819 (2015). https://doi.org/10.1007/s12253-015-9896-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-015-9896-9